179 related articles for article (PubMed ID: 23202794)
1. Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.
Meyer C; Sims AH; Morgan K; Harrison B; Muir M; Bai J; Faratian D; Millar RP; Langdon SP
Endocr Relat Cancer; 2013 Feb; 20(1):123-36. PubMed ID: 23202794
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin.
Gründker C; Schlotawa L; Viereck V; Emons G
Eur J Endocrinol; 2001 Nov; 145(5):651-8. PubMed ID: 11720885
[TBL] [Abstract][Full Text] [Related]
3. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo.
Morgan K; Stewart AJ; Miller N; Mullen P; Muir M; Dodds M; Medda F; Harrison D; Langdon S; Millar RP
Cancer Res; 2008 Aug; 68(15):6331-40. PubMed ID: 18676858
[TBL] [Abstract][Full Text] [Related]
5. Radiation response and regulation of apoptosis induced by a combination of TRAIL and CHX in cells lacking mitochondrial DNA: a role for NF-κB-STAT3-directed gene expression.
Ivanov VN; Ghandhi SA; Zhou H; Huang SX; Chai Y; Amundson SA; Hei TK
Exp Cell Res; 2011 Jul; 317(11):1548-66. PubMed ID: 21440540
[TBL] [Abstract][Full Text] [Related]
6. GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.
Morgan K; Meyer C; Miller N; Sims AH; Cagnan I; Faratian D; Harrison DJ; Millar RP; Langdon SP
BMC Cancer; 2011 Nov; 11():476. PubMed ID: 22051164
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells.
Gründker C; Schulz K; Günthert AR; Emons G
J Clin Endocrinol Metab; 2000 Oct; 85(10):3815-20. PubMed ID: 11061544
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells.
Teng LH; Ahmad M; Ng WT; Sabaratnam S; Rasan MI; Parhar I; Khoo AS
Mol Med Rep; 2015 Oct; 12(4):4909-16. PubMed ID: 26151677
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus.
Ge Y; Xu Y; Sun W; Man Z; Zhu L; Xia X; Zhao L; Zhao Y; Wang X
Gene; 2012 Oct; 508(2):157-64. PubMed ID: 22903029
[TBL] [Abstract][Full Text] [Related]
10. Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.
Yan M; Xu Q; Zhang P; Zhou XJ; Zhang ZY; Chen WT
BMC Cancer; 2010 Aug; 10():437. PubMed ID: 20716363
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
12. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone receptor-targeted gene therapy of gynecologic cancers.
Gründker C; Huschmand Nia A; Emons G
Mol Cancer Ther; 2005 Feb; 4(2):225-31. PubMed ID: 15713894
[TBL] [Abstract][Full Text] [Related]
14. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
Hernandez L; Hsu SC; Davidson B; Birrer MJ; Kohn EC; Annunziata CM
Cancer Res; 2010 May; 70(10):4005-14. PubMed ID: 20424119
[TBL] [Abstract][Full Text] [Related]
15. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
16. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y
Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
19. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.
Tang B; Tang F; Wang Z; Qi G; Liang X; Li B; Yuan S; Liu J; Yu S; He S
Int J Nanomedicine; 2016; 11():6401-6420. PubMed ID: 27942213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
